来自西北安纳托利亚的植物表现出选择性细胞毒性,并诱导线虫灾难:关于抗癌和基因毒性活动的研究
Mehmet Sarimahmut1, Serap Celikler1
1Department of Biology, Faculty of Science and Arts, Bursa Uludag University, Bursa, 16059, Turkey.
Chemistry & biodiversity
|July 21, 2023
概括
来自安纳托利亚的植物提取物显示出抗癌性质. 阿奇利亚多和阿斯特拉加卢斯西伯索皮亚努斯提取物显示出显著的细胞毒性,诱导乳腺癌细胞系中的细胞死亡,突出显示了它们的治疗潜力.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 癌症生物学 癌症生物学
背景情况:
- 安纳托利亚拥有丰富的植物多样性和高度的特有性.
- 乳腺癌仍然是一个重大的全球健康挑战,需要新的治疗策略.
- 自然产品是发现抗癌剂的有希望的来源.
研究的目的:
- 评估来自西北安纳托利亚的八种植物对乳腺癌细胞系的抗生长特性.
- 为了确定有效提取物的活性化合物和作用机制.
- 评估植物提取物对恶性与非恶性乳腺细胞的选择性细胞毒性.
主要方法:
- 对两个恶性 (MCF-7,MDA-MB-231) 和一个非恶性 (MCF-10A) 人类乳腺细胞系进行了细胞毒性测试.
- 高性能液态色谱 (HPLC) 用于识别主要的化合物.
- 研究了细胞死亡的机制,包括细胞亡和DNA损伤.
主要成果:
- 阿奇利亚多种 (AME) 提取物和阿斯特拉加卢斯西伯索皮亚努斯 (ASE) 提取物表现出显著的抗生长活性.
- AME 含有基酸;ASE 含有甲基素.
- ASE显示对癌细胞具有选择性细胞毒性,而AME则以剂量依赖的方式诱导DNA损伤和细胞死亡,通过细胞亡和线粒灾难.
结论:
- 来自安纳托利亚的植物物种对乳腺癌细胞具有相当大的细胞毒性潜力.
- ASE和AME代表了作为抗癌剂进一步调查的有希望的候选人.
- 这些发现强调了为潜在的药用应用保护安纳托利亚独特动植物的重要性.
相关概念视频
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


